Fluxome addresses bankruptcy rumors

Fluxome addresses bankruptcy rumors

Company says it's "business as usual" for the resveratrol operation, and customers should not notice any disruption in supply.

Fluxome A/S, Danish based parent to Fluxome Inc., recently filed for formal reconstruction. This action was taken in part to preserve assets for its U.S. commercial operations for the production and selling of resveratrol. At this time, the Danish facility has closed its research activities during this reconstruction phase.

Fluxome A/S, while in reconstruction, is in the process of obtaining additional funding to continue its operations both here and abroad and/or a sale of its assets. In the meantime, it is business as usual for the resveratrol operation and customers should not notice any disruption in supply.

Questions or media inquiries should be sent directly to Angela Tsetsis at [email protected] or Laura Moreno-Hill, Director of Marketing, at [email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.